Published in Ann N Y Acad Sci on December 01, 2003
Imidazoline binding sites on receptors and enzymes: emerging targets for novel antidepressant drugs? J Psychiatry Neurosci (2003) 0.76
Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands. Br J Pharmacol (2004) 0.75
Modeling sensitization to stimulants in humans: an [11C]raclopride/positron emission tomography study in healthy men. Arch Gen Psychiatry (2006) 1.78
Rapid improvement of acute schizophrenia symptoms after intravenous sodium nitroprusside: a randomized, double-blind, placebo-controlled trial. JAMA Psychiatry (2013) 1.56
Functional neuroimaging of minocycline's effect in a patient with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.43
Bioactive contaminants leach from disposable laboratory plasticware. Science (2008) 1.42
Microglia in cerebral ischemia: molecular actions and interactions. Can J Physiol Pharmacol (2006) 1.36
Laser speckle contrast imaging of collateral blood flow during acute ischemic stroke. J Cereb Blood Flow Metab (2010) 1.34
Differential regulation of trophic and proinflammatory microglial effectors is dependent on severity of neuronal injury. Glia (2008) 1.20
Brain-derived neurotrophic factor drives the changes in excitatory synaptic transmission in the rat superficial dorsal horn that follow sciatic nerve injury. J Physiol (2009) 1.19
Serine racemase is associated with schizophrenia susceptibility in humans and in a mouse model. Hum Mol Genet (2009) 1.18
Hypoxia-activated microglial mediators of neuronal survival are differentially regulated by tetracyclines. Glia (2006) 1.12
Matrix metalloproteinase activation and blood-brain barrier breakdown following thrombolysis. Exp Neurol (2006) 1.11
Impaired neurosteroid synthesis in multiple sclerosis. Brain (2011) 1.05
Antenatal sildenafil treatment attenuates pulmonary hypertension in experimental congenital diaphragmatic hernia. Circulation (2011) 1.04
Mood-elevating effects of d-amphetamine and incentive salience: the effect of acute dopamine precursor depletion. J Psychiatry Neurosci (2007) 1.03
Aldehyde load in ischemia-reperfusion brain injury: neuroprotection by neutralization of reactive aldehydes with phenelzine. Brain Res (2006) 1.03
Monoamine oxidase inhibition during brain development induces pathological aggressive behavior in mice. Biol Psychiatry (2002) 1.03
The effects of intraspinal microstimulation on spinal cord tissue in the rat. Biomaterials (2010) 1.02
Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia. J Cereb Blood Flow Metab (2005) 1.00
The antipsychotic potential of l-stepholidine--a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Psychopharmacology (Berl) (2008) 1.00
Decreasing amphetamine-induced dopamine release by acute phenylalanine/tyrosine depletion: A PET/[11C]raclopride study in healthy men. Neuropsychopharmacology (2004) 1.00
Glutamate system, amyloid ß peptides and tau protein: functional interrelationships and relevance to Alzheimer disease pathology. J Psychiatry Neurosci (2013) 0.99
Genetic inactivation of D-amino acid oxidase enhances extinction and reversal learning in mice. Learn Mem (2008) 0.98
Glia contribute to the purinergic modulation of inspiratory rhythm-generating networks. J Neurosci (2010) 0.98
Determination of d-serine and related neuroactive amino acids in human plasma by high-performance liquid chromatography with fluorimetric detection. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.98
Combining bupropion SR with venlafaxine, paroxetine, or fluoxetine: a preliminary report on pharmacokinetic, therapeutic, and sexual dysfunction effects. J Clin Psychiatry (2002) 0.95
Interactions between the cytochrome P450 system and the second-generation antipsychotics. J Psychiatry Neurosci (2003) 0.93
Homocysteine reduces endothelial progenitor cells in stroke patients through apoptosis. J Cereb Blood Flow Metab (2008) 0.91
Synthesis, transport, and metabolism of serotonin formed from exogenously applied 5-HTP after spinal cord injury in rats. J Neurophysiol (2013) 0.91
The antidepressant phenelzine protects neurons and astrocytes against formaldehyde-induced toxicity. J Neurochem (2010) 0.89
Doxycycline inhibits proinflammatory cytokines but not acute cerebral cytogenesis after hypoxia-ischemia in neonatal rats. J Psychiatry Neurosci (2010) 0.88
D-serine and schizophrenia: an update. Expert Rev Neurother (2012) 0.88
Long-term actions of interleukin-1beta on delay and tonic firing neurons in rat superficial dorsal horn and their relevance to central sensitization. Mol Pain (2008) 0.88
Increased glutamate levels in the medial prefrontal cortex in patients with postpartum depression. Neuropsychopharmacology (2012) 0.87
Impaired hippocampal LTP in inbred mouse strains can be rescued by beta-adrenergic receptor activation. Eur J Neurosci (2007) 0.87
Relationship of plasma amphetamine levels to physiological, subjective, cognitive and biochemical measures in healthy volunteers. Hum Psychopharmacol (2003) 0.86
Increased cholesterol levels during paroxetine administration in healthy men. J Clin Psychiatry (2003) 0.85
Neonatal rat microglia derived from different brain regions have distinct activation responses. Neuron Glia Biol (2011) 0.85
The MAO inhibitor phenelzine improves functional outcomes in mice with experimental autoimmune encephalomyelitis (EAE). Brain Behav Immun (2011) 0.85
Persistent neurochemical changes in neonatal piglets after hypoxia-ischemia and resuscitation with 100%, 21% or 18% oxygen. Resuscitation (2008) 0.84
Paroxetine-induced increase in metabolic end products of nitric oxide. J Clin Psychopharmacol (2003) 0.84
Neurosteroid-mediated regulation of brain innate immunity in HIV/AIDS: DHEA-S suppresses neurovirulence. FASEB J (2012) 0.84
The interplay of cannabinoid and NMDA glutamate receptor systems in humans: preliminary evidence of interactive effects of cannabidiol and ketamine in healthy human subjects. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.84
Postresuscitation N-acetylcysteine treatment reduces cerebral hydrogen peroxide in the hypoxic piglet brain. Intensive Care Med (2007) 0.84
Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance. Psychopharmacology (Berl) (2010) 0.84
Neurochemical effects of the monoamine oxidase inhibitor phenelzine on brain GABA and alanine: A comparison with vigabatrin. J Pharm Pharm Sci (2008) 0.84
An update on amine oxidase inhibitors: multifaceted drugs. Prog Neuropsychopharmacol Biol Psychiatry (2013) 0.82
Multiple 5-HT receptors are involved in the effects of acute MDMA treatment: studies on locomotor activity and responding for conditioned reinforcement. Psychopharmacology (Berl) (2002) 0.82
Effects of sciatic nerve axotomy on excitatory synaptic transmission in rat substantia gelatinosa. J Neurophysiol (2009) 0.82
Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects. Psychopharmacology (Berl) (2004) 0.81
The effects of a low protein diet on amino acids and enzymes in the serine synthesis pathway in mice. Amino Acids (2009) 0.81
Role of serotonin (5-HT) in the antidepressant-like properties of neuropeptide Y (NPY) in the mouse forced swim test. Peptides (2005) 0.81
A dose-response study of graded reoxygenation on the carotid haemodynamics, matrix metalloproteinase-2 activities and amino acid concentrations in the brain of asphyxiated newborn piglets. Resuscitation (2006) 0.81
Paroxetine-induced increase in metabolic end products of nitric oxide. J Clin Psychopharmacol (2003) 0.81
Neuroactive steroids and anxiety disorders. J Psychiatry Neurosci (2002) 0.81
Zero net flux estimates of septal extracellular glucose levels and the effects of glucose on septal extracellular GABA levels. Eur J Pharmacol (2009) 0.80
Determination of L-serine-O-phosphate in rat and mouse brain tissue using high-performance liquid chromatography and fluorimetric detection. Anal Biochem (2010) 0.80
Amine oxidases and their inhibitors: what can they tell us about neuroprotection and the development of drugs for neuropsychiatric disorders? J Psychiatry Neurosci (2007) 0.80
Monoamine oxidase inhibitors and neuroprotection: a review. Am J Ther (2012) 0.80
Cerebral amino acid profiles after hypoxia-reoxygenation and N-acetylcysteine treatment in the newborn piglet. Neonatology (2009) 0.79
Effect of lamotrigine on plasma GABA levels in healthy humans. Prog Neuropsychopharmacol Biol Psychiatry (2003) 0.79
Quantification of l-stepholidine in rat brain and plasma by high performance liquid chromatography combined with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.79
Effects of the antidepressant/antipanic drug phenelzine and its putative metabolite phenylethylidenehydrazine on extracellular gamma-aminobutyric acid levels in the striatum. Biochem Pharmacol (2002) 0.79
HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance. AIDS (2016) 0.79
The pharmacology and formulation of paliperidone extended release. Expert Rev Neurother (2012) 0.78
Tissue concentration changes of amino acids and biogenic amines in the central nervous system of mice with experimental autoimmune encephalomyelitis (EAE). Neurochem Int (2011) 0.78
Individual differences in frontal cortical thickness correlate with the d-amphetamine-induced striatal dopamine response in humans. J Neurosci (2013) 0.78
The effects of doxycycline administration on amino acid neurotransmitters in an animal model of neonatal hypoxia-ischemia. Neurochem Int (2006) 0.78
L-Serine-O-phosphate in the central nervous system. Brain Res (2009) 0.78
Recent developments in the regulation of monoamine oxidase form and function: is the current model restricting our understanding of the breadth of contribution of monoamine oxidase to brain [dys]function? Curr Top Med Chem (2012) 0.77
Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition. Neurochem Res (2007) 0.77
Nitric oxide plasma/serum levels in patients with schizophrenia: a systematic review and meta-analysis. Rev Bras Psiquiatr (2012) 0.77
Hyaluronic acid-based 3D culture model for in vitro testing of electrode biocompatibility. Biomacromolecules (2014) 0.77
Monoamine oxidase inhibitors, their structural analogues, and neuroprotection. Indian J Exp Biol (2004) 0.77
The effects of sodium nitroprusside treatment on cognitive deficits in schizophrenia: a pilot study. J Clin Psychopharmacol (2015) 0.77
Cardiac risk and schizophrenia. J Psychiatry Neurosci (2005) 0.77
The MAO inhibitor phenelzine can improve functional outcomes in mice with established clinical signs in experimental autoimmune encephalomyelitis (EAE). Behav Brain Res (2013) 0.77
Projections of the nucleus lentiformis mesencephali in pigeons (Columba livia): a comparison of the morphology and distribution of neurons with different efferent projections. J Comp Neurol (2006) 0.77
Nitric oxide: a key player in the relation between cardiovascular disease and major depressive disorder? J Psychiatry Neurosci (2004) 0.77
Glycine reuptake inhibition: a promising therapeutic strategy in the treatment of schizophrenia? Future Med Chem (2013) 0.76
Inferior olivary neurons innervate multiple zones of the flocculus in pigeons (Columba livia). J Comp Neurol (2005) 0.76
Metabolism of N-methyl, N-propargylphenylethylamine: studies with human liver microsomes and cDNA expressed cytochrome P450 (CYP) enzymes. Cell Mol Neurobiol (2006) 0.76
Sodium nitroprusside treatment of clozapine-refractory schizophrenia. J Clin Psychopharmacol (2014) 0.76
Targeting the NMDA receptor-nitric oxide-cyclic GMP pathway to develop non-dopaminergic antipsychotic medications for schizophrenia. Rev Bras Psiquiatr (2011) 0.76
Long-term effects of fluoxetine or vehicle administration during pregnancy on behavioral outcomes in guinea pig offspring. Psychopharmacology (Berl) (2004) 0.76
Determination of rat hepatic polyamines by electron-capture gas chromatography. J Pharmacol Toxicol Methods (2004) 0.76
Moving past the "neuroncentric" perspective: a role for glia in neuropsychiatric disorders. J Psychiatry Neurosci (2009) 0.75
Effects of pregabalin on behavioral alterations induced by ketamine in rats. Rev Bras Psiquiatr (2012) 0.75
Annual high-dose vitamin D supplementation does not affect mental well-being in older women. Evid Based Ment Health (2011) 0.75
Comparison of phenelzine and geometric isomers of its active metabolite, β-phenylethylidenehydrazine, on rat brain levels of amino acids, biogenic amine neurotransmitters and methylamine. J Neural Transm (Vienna) (2013) 0.75
Arvid Carlsson, and the story of dopamine. Indian J Psychiatry (2010) 0.75
Chirality and drugs used to treat psychiatric disorders. J Psychiatry Neurosci (2002) 0.75
Clonidine potentiates the effects of tranylcypromine, phenelzine and two analogues in the forced swimming test in mice. J Psychiatry Neurosci (2002) 0.75
Zonal organization of the vestibulocerebellum in pigeons (Columba livia): II. Projections of the rotation zones of the flocculus. J Comp Neurol (2003) 0.75
Clozapine treatment of patients with refractory schizophrenia, concurrent dengue infection and hematological abnormalities: three case reports. Ther Adv Psychopharmacol (2013) 0.75
Allosteric modulation of semicarbazide-sensitive amine oxidase activities in vitro by imidazoline receptor ligands. Br J Pharmacol (2004) 0.75